Inventor · disambiguated record
Jack Guoen Shi
Also filed as: SHI JACK GUOEN
3 granted patents·4 pending applications·225 citations·filing 2008–2020
78Inventor score
Top patents by PatentIndex Score
7 records- 0197US8889697B2Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileRODGERS JAMES D·Filed 2010·Granted Nov 18, 2014·79 cites·6 claims
- 0295US7834022B2Metabolites of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2008·Granted Nov 16, 2010·141 cites·11 claims
- 0392US10463667B2Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2017·Granted Nov 5, 2019·5 cites·26 claims
- 0475US2020038404A1METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILEINCYTE CORP·Filed 2019·Application pending·0 cites
- 0572US2015164900A1METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILEINCYTE CORP·Filed 2014·Application pending·0 cites
- 0654US2020179347A1Pharmaceutical compositions and methods for indoleamine, 2, 3-dioxygenase inhibition and indications thereforINCYTE CORP·Filed 2020·Application pending·0 cites
- 0744US2018353483A1Pharmaceutical compositions and methods for indoleamine, 2, 3-dioxygenase inhibition and indications thereforINCYTE CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jack Guoen Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →